Quick Answer
Armata Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $8.69 million for the year ending 2025.
- Armata Pharmaceuticals, Inc. showed a decrease of -6.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Armata Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Armata Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 907.9%.
- Historical annual values: Fiscal year 2025: $8.69 million | Fiscal year 2024: $9.29 million | Fiscal year 2023: $13.52 million | Fiscal year 2022: $14.85 million | Fiscal year 2021: $10.29 million | Fiscal year 2020: $9.65 million | Fiscal year 2019: $6.03 million | Fiscal year 2018: $9.66 million | Fiscal year 2017: $5.13 million | Fiscal year 2016: $5.71 million | Fiscal year 2015: $9.37 million | Fiscal year 2014: $6.58 million | Fiscal year 2013: $20.36 million | Fiscal year 2012: $862.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: